Monthly Archives: March 2021

First Canadian dose of Biosimilar Adalimumab (Amgevita) administered at Charlton Health!

Posted on March 10, 2021 by admin

Charlton Health is proud to announce that the first dose in Canada of the biosimilar adalimumab, known as Amgevita (produced by Amgen), was injected at Charlton Health on February 22, 2021. Five biosimilars of adalimumab were released onto the Canadian market … Continue reading →

Posted in The Charlton Centre | Leave a comment